Lymphoma is a type of cancer that begins in the lymphatic system, which is crucial for the body's immune defense. Non-Hodgkin lymphoma (NHL) is more common than Hodgkin lymphoma (HL), with NHL representing the majority of lymphoma cases worldwide1 . While both diseases originate from lymphocytes, they differ in their cellular characteristics, age distribution, and prognosis1 . Understanding these differences is essential for accurate diagnosis and effective treatment2 .
Difference Between Hodgkin vs. Non-Hodgkin Lymphoma
Hodgkin lymphoma accounts for about 1% of all cancers globally and has a bimodal age distribution, with peaks in young adults and older adults3 4. In contrast, non-Hodgkin lymphoma is much more common, representing the majority of lymphomas, and its incidence increases with age5 6. NHL comprises a diverse group of disorders, mostly of B-cell origin, while HL is defined by the presence of distinctive Reed-Sternberg cells5 7.
Reed-Sternberg Cells
The hallmark of Hodgkin lymphoma is the presence of Reed-Sternberg cells, which are large, abnormal B lymphocytes with prominent nucleoli7 . These cells often have two nuclei, giving them an "owl's eyes" appearance under the microscope8 . In classic Hodgkin lymphoma (CHL), these Hodgkin and Reed-Sternberg cells are surrounded by an inflammatory background7 . Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), a less common subtype, features lymphocytic and histiocytic "popcorn" cells9 . Non-Hodgkin lymphoma lacks Reed-Sternberg cells, distinguishing it from HL7 .
Type Classification
The World Health Organization (WHO) classification system is the international standard for diagnosing and subclassifying both HL and NHL, reflecting advances in molecular and immunophenotypic understanding10 11. HL is divided mainly into classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma12 . NHL includes over 60 subtypes, broadly categorized into B-cell lymphomas (about 95% of cases) and less common T-cell and natural killer (NK) cell lymphomas5 . NHL subtypes range from indolent forms like follicular lymphoma to aggressive types such as diffuse large B-cell lymphoma (DLBCL) 13.
| Feature | Hodgkin Lymphoma (HL) | Non-Hodgkin Lymphoma (NHL) |
|---|---|---|
| Presence of Reed-Sternberg cells | Yes7 8 | No7 8 |
| Main cell origin | B lymphocytes | Mostly B lymphocytes; some T and NK cells5 |
| Subtypes | Classic HL, Nodular lymphocyte-predominant HL12 9 | >60 subtypes including DLBCL, follicular lymphoma5 13 |
| Inflammatory background | Prominent in CHL7 | Usually absent, except rare types2 |
| Age distribution | Bimodal: young adults and older adults3 4 | Increases with age; median ~67 years5 6 |
| Sources: 12345678910111213 | ||
Hodgkin vs. Non-Hodgkin Lymphoma: Symptoms
Both Hodgkin and non-Hodgkin lymphoma can present with similar systemic symptoms known as "B symptoms," which include fever, night sweats, and unexplained weight loss14 15. However, HL more commonly presents with localized lymphadenopathy, especially in the neck, chest, groin, and armpits1 2. Unique features of HL include pruritus (itching) and lymph node pain triggered by alcohol consumption, which are rarely seen in NHL2 .
Non-Hodgkin lymphoma often involves extranodal sites (outside the lymph nodes), leading to a broader range of symptoms depending on the organ affected14 . For example, NHL can cause abdominal pain, chest pain, cough, or breathing difficulties if it involves the gastrointestinal tract, lungs, or mediastinum14 . Fatigue and persistent fever are common in both types14 .
- Common symptoms shared by HL and NHL:
- Painless swelling of lymph nodes in neck, armpits, or groin14
- Fever and night sweats14
- Unexplained weight loss14
- Fatigue14
- Symptoms more specific to Hodgkin lymphoma:
- Pruritus (itching) 2
- Alcohol-induced lymph node pain2
- Localized lymphadenopathy1
- Symptoms more common in Non-Hodgkin lymphoma:
- Extranodal involvement causing organ-specific symptoms (e.g., abdominal pain, cough) 14
Causes of Hodgkin vs. Non-Hodgkin Lymphoma
The exact causes of both Hodgkin and non-Hodgkin lymphoma remain incompletely understood13 16. Both diseases arise from genetic mutations in lymphocytes that lead to uncontrolled cell growth14 . Epstein-Barr virus (EBV) infection is implicated in a significant proportion of classical Hodgkin lymphoma cases, especially in elderly and immunocompromised patients3 16. For NHL, the etiology is multifactorial, involving immune dysfunction, chronic antigenic stimulation, infections such as HIV and hepatitis C, and environmental exposures like pesticides and solvents13 .
Risk Factors
- Viral infections:
- Epstein-Barr virus (EBV) linked to HL and some NHL subtypes3 1316
- Human immunodeficiency virus (HIV) increases risk for both HL and NHL13 14
- Hepatitis C virus associated with certain NHL subtypes13
- Immune system dysfunction:
- Immunosuppression after organ transplant or due to autoimmune diseases13 14
- Environmental exposures:
- Pesticides, solvents, and other chemicals linked to NHL risk13 14
- Age:
- HL shows a bimodal age distribution with peaks in young adults and older adults3 4
- NHL risk increases with age, most common in adults over 605 6
- Family history:
- Minor risk factor for both HL and NHL13 14
Treatment for Hodgkin and Non-Hodgkin Lymphoma
Treatment approaches differ significantly between Hodgkin and non-Hodgkin lymphoma due to their distinct biology and clinical behavior. Hodgkin lymphoma is highly curable, especially in early stages, typically treated with a combination of chemotherapy (e.g., ABVD regimen) and radiation therapy2 17. For advanced HL, novel biologic agents targeting specific lymphoma proteins may be added2 . Stem cell transplantation is reserved for relapsed or refractory cases2 .
Non-Hodgkin lymphoma treatment varies widely depending on the subtype and aggressiveness. Indolent NHLs may be managed with watchful waiting until symptoms develop, while aggressive NHLs require intensive chemoimmunotherapy18 . Common chemotherapy regimens include R-CHOP for many B-cell NHLs and R-EPOCH for more aggressive forms2 . Immunotherapy options, such as checkpoint inhibitors and CAR T-cell therapy, have expanded treatment possibilities, especially for relapsed or refractory NHL2 19.
- Hodgkin lymphoma treatment:
- Combination chemotherapy and radiation for early-stage disease2
- Addition of biologic agents for advanced cases2
- Stem cell transplantation for relapsed/refractory disease2
- Non-Hodgkin lymphoma treatment:
- Watchful waiting for indolent subtypes18
- Chemotherapy regimens like R-CHOP and R-EPOCH depending on aggressiveness2
- Immunotherapy including checkpoint inhibitors and CAR T-cell therapy19 2
- Stem cell transplantation for select cases2
It is important to remember that even when non-Hodgkin lymphoma isn’t curable, current treatments are helping people live longer, fuller lives with this disease18 .
Living With Hodgkin vs. Non-Hodgkin Lymphoma
Living with lymphoma depends heavily on the type and stage of disease. Hodgkin lymphoma patients often achieve remission or cure with initial treatment and have a good long-term prognosis17 . However, treatment side effects and late complications such as secondary cancers and cardiovascular disease require ongoing monitoring2 .
Non-Hodgkin lymphoma encompasses a broad spectrum of diseases with variable outcomes. Some indolent NHLs behave like chronic conditions, with patients living many years without immediate treatment20 . Aggressive NHLs may require intensive therapy but can also achieve remission. Quality of life considerations include managing treatment side effects, fatigue, and psychological impacts13 18.
- HL survivors generally have high cure rates but need monitoring for late effects17 2
- NHL patients may experience prolonged disease courses, especially with indolent types20 13
- Fatigue and psychological symptoms are common in both HL and NHL survivors13
- Supportive care and regular follow-up are essential for managing long-term health18
Frequently Asked Questions
What is the main difference between Hodgkin and non-Hodgkin lymphoma?
Hodgkin lymphoma is defined by the presence of Reed-Sternberg cells, while non-Hodgkin lymphoma lacks these cells and includes many diverse subtypes7 8.
Which lymphoma is more common?
Non-Hodgkin lymphoma is much more common than Hodgkin lymphoma worldwide5 1.
Are the symptoms of Hodgkin and non-Hodgkin lymphoma different?
Both can present with similar systemic symptoms like fever, night sweats, and weight loss, but Hodgkin lymphoma often has localized lymph node swelling and unique symptoms such as alcohol-induced pain2 14.
Is Hodgkin lymphoma curable?
Yes, Hodgkin lymphoma has among the highest cure rates of any cancer, especially when diagnosed early17 .
Can non-Hodgkin lymphoma be cured?
Some aggressive NHL subtypes are curable, but many indolent NHLs are managed as chronic conditions with long survival20 13.
